Academic research generates many of the most promising biologics concepts – but a result that works in a research lab is not yet a process that can be developed, transferred or funded. Z2 helps academic groups view their science through an industrial development lens, identifying what needs to change as a concept progresses towards a reproducible, scalable and manufacturable process.
With a PhD and postdoctoral research at The University of Manchester, and experience of securing more than £3 million in research and innovation funding, Z2's founder understands both sides of the translation gap.
How Z2 helps
- Research processes made scalable
- CMC input for spin-outs and grant applications
- Translational bioprocess strategy from proof-of-concept onwards
- Laboratory capability, workflows and GMO/biosafety readiness
- Industry-relevant training in DoE, QbD, upstream PD and AI/ML
Where rushed timelines break
Strong proof-of-concept data alongside a process that cannot scale – a mismatch that is usually invisible to non-technical funders.
Where Z2 helps
An industrial view of the process early, and a scientifically credible development and funding narrative.